Sermonix Pharmaceuticals
Sermonix Pharmaceuticals, founded by David Portman, MD—a leading clinical researcher and expert in women’s health—focuses on developing targeted therapeutics to treat ESR1-mutated metastatic breast and gynecological cancers. Our ELAINE Studies are evaluating an investigational oral drug, lasofoxifene, a novel targeted endocrine agent, in women and men with locally advanced or metastatic estrogen receptor-positive/human epidermal growth factor 2-negative (ER+/HER2-) breast cancer harboring an ESR1 mutation(s).
7-day free trial · no credit card
Verified contacts
6
available on Kipplo
LinkedIn employees
10
11 to 50 range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
1
tools in use
Monthly traffic
173
organic / mo
Sign up free to see all 6 verified contacts at Sermonix Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
6 contacts with verified email or phone · masked until revealed.
- EA
Elizabeth Attias
Chief Strategy and Business Development Officer · General Business & Management
EmailPhone - GG
Gina Gasper Boruta
Clinical Project Manager · Operations
EmailPhone - MK
Monica Kozlowski
Product Manager · Sales & Business Development
EmailPhone - JG
Joe Guillory
Controller at Sermonix Pharmaceuticals, Inc · Other
EmailPhone
Showing 4 of 6 verified contacts
Top roles at Sermonix Pharmaceuticals
6 distinct titles indexed · top 6 shown.
- 1chief strategy and business development officer
- 1clinical outsourcing consultant
- 1clinical project manager
- 1controller at sermonix pharmaceuticals, inc
- 1pharmaceutical consultant
- 1product manager
Sign up to unlock all 6 contacts at Sermonix Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 6 verified contacts at Sermonix Pharmaceuticals
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.